StonvexLoading…
StonvexStonvexStonvexCore line items from BLLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $305.11M | $152.58M | $71.73M |
Operating Income | $16.02M | $-47.15M | $-69.50M |
Net Income | $7.45M | $-41.57M | $-82.68M |
EPS (Diluted) | $0.14 | $-4.12 | $-8.45 |
Total Assets | $632.65M | $302.06M | Not available |
Total Liabilities | $152.55M | $134.31M | Not available |
Cash & Equivalents | $495.98M | $191.48M | $97.27M |
Free Cash Flow OCF − CapEx | $15.71M | $-46.78M | $-59.85M |
Shares Outstanding | 21.23M | 10.08M | 9.78M |